Labcorp Holdings Inc. (LH) To Go Ex-Dividend on February 27th

Labcorp Holdings Inc. (NYSE:LH) declared a quarterly dividend on Wednesday, January 14th. Shareholders of record on Friday, February 27th will be given a dividend of 0.72 per share by the medical research company on Thursday, March 12th. This represents a c) annualized dividend and a yield of 1.0%. The ex-dividend date is Friday, February 27th.

Labcorp has a dividend payout ratio of 16.4% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Labcorp to earn $17.54 per share next year, which means the company should continue to be able to cover its $2.88 annual dividend with an expected future payout ratio of 16.4%.

Labcorp Trading Up 0.8%

Shares of Labcorp stock opened at $287.56 on Wednesday. Labcorp has a twelve month low of $209.38 and a twelve month high of $293.72. The company has a quick ratio of 1.23, a current ratio of 1.42 and a debt-to-equity ratio of 0.60. The business has a 50-day moving average price of $266.52 and a 200-day moving average price of $269.64. The firm has a market cap of $23.84 billion, a price-to-earnings ratio of 27.49, a PEG ratio of 1.95 and a beta of 1.03.

Labcorp (NYSE:LH) last released its quarterly earnings results on Tuesday, February 17th. The medical research company reported $4.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.95 by $0.12. Labcorp had a net margin of 6.28% and a return on equity of 16.16%. The company had revenue of $3.52 billion for the quarter, compared to the consensus estimate of $3.56 billion. During the same quarter in the prior year, the firm earned $3.45 earnings per share. Labcorp’s revenue was up 5.6% on a year-over-year basis. Labcorp has set its FY 2026 guidance at 17.550-18.250 EPS. Equities research analysts anticipate that Labcorp will post 16.01 EPS for the current fiscal year.

Labcorp Company Profile

Laboratory Corporation of America Holdings, commonly known as Labcorp (NYSE: LH), is a global life sciences company that provides comprehensive clinical laboratory and drug development services. The company operates a broad network of laboratories, patient service centers and specialty testing sites to deliver diagnostic information and testing solutions that support patient care, clinical decision-making and population health initiatives.

Labcorp’s core businesses encompass clinical laboratory testing and pharmaceutical development services.